539997 — Kwality Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
- IN₹5.26bn
- IN₹6.09bn
- IN₹2.51bn
- 66
- 29
- 82
- 66
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,663 | 1,393 | 2,620 | 4,562 | 2,510 |
Cost of Revenue | |||||
Gross Profit | 468 | 522 | 964 | 2,556 | 1,410 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,537 | 1,295 | 2,397 | 2,952 | 2,224 |
Operating Profit | 126 | 97.6 | 224 | 1,610 | 287 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 109 | 109 | 213 | 1,616 | 256 |
Provision for Income Taxes | |||||
Net Income After Taxes | 75.6 | 82.1 | 149 | 1,199 | 193 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 75.5 | 83.2 | 151 | 1,200 | 194 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 75.5 | 83.2 | 151 | 1,200 | 194 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.28 | 8.02 | 14.6 | 116 | 30.6 |